Taiwan FDA registration bf0b17b306ad5275faf1732ffcd67ca6
"Rhodes" rapid pregnancy test reagent series
TW: “羅得” 快速驗孕試劑系列
Taiwan·Risk Class 2·Rhodes International Limited;; Dongyao Biotechnology Co., Ltd·Registered Aug 27, 2015 – Sep 28, 2025CancelledRegistration details
- Analysis ID
- bf0b17b306ad5275faf1732ffcd67ca6
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Rhodes International Limited
Product details
- Intended Use
- Urine is tested qualitatively for human chorionic gonadotropin (HCG).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic;; Contract manufacturing
Dates and status
- Registration Date
- Aug 27, 2015
- Expiry Date
- Sep 28, 2025
- Cancellation Date
- Sep 19, 2023
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for "Rhodes" rapid pregnancy test reagent series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bf0b17b306ad5275faf1732ffcd67ca6 and manufactured by Rhodes International Limited;; Dongyao Biotechnology Co., Ltd. The authorized representative in Taiwan is Rhodes International Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices